KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Assets Average (2020 - 2025)

Royalty Pharma (RPRX) has disclosed Assets Average for 6 consecutive years, with $19.5 billion as the latest value for Q4 2025.

  • Quarterly Assets Average rose 7.45% to $19.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.5 billion through Dec 2025, up 7.45% year-over-year, with the annual reading at $18.9 billion for FY2025, 9.36% up from the prior year.
  • Assets Average hit $19.5 billion in Q4 2025 for Royalty Pharma, up from $18.8 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $19.5 billion in Q4 2025 to a low of $16.0 billion in Q1 2021.
  • Historically, Assets Average has averaged $17.3 billion across 5 years, with a median of $17.3 billion in 2022.
  • Biggest five-year swings in Assets Average: dropped 6.88% in 2023 and later rose 12.49% in 2024.
  • Year by year, Assets Average stood at $17.6 billion in 2021, then decreased by 2.16% to $17.2 billion in 2022, then fell by 6.52% to $16.1 billion in 2023, then rose by 12.49% to $18.1 billion in 2024, then rose by 7.45% to $19.5 billion in 2025.
  • Business Quant data shows Assets Average for RPRX at $19.5 billion in Q4 2025, $18.8 billion in Q3 2025, and $18.0 billion in Q2 2025.